Issue link: https://www.e-digitaleditions.com/i/1138630
Tablets & Capsules July 2019 39 The driving force for choosing a particular excipient is its functionality, such as diluting the formulation, enhancing the API's therapeutic performance, enhancing solubility, facilitating powder flow, reducing sticking and picking potential, and more. However, understanding the mechanical characteristics of a drug product's excipients under known tableting conditions can pay long-term div- idends when the product is ready to be scaled up for high-speed production. T&C Robert Sedlock is director of technical training and develop- ment for Natoli Engineering (636 926 8900, www.natoli. com). Sedlock is responsible for global solid dosage customer support, training seminars, contract compression services, and continuous research at the Natoli Scientific laboratory in Tel- ford, PA, as well as the Natoli Institute of Industrial Phar- macy at the Long Island University AMS College of Phar- macy and Health Sciences in Brooklyn, NY. Special acknowledgements to Rutesh H. Dave and Pratap Basim at Long Island University/AMS College of Pharmacy and Health Sciences and to Prashanth Babashyam and John Stur- gis at Natoli Scientific. Figure 2 PCA score plot of commonly used excipients grouped by deformation mechanism

